Fleming Harold Edward 4
4 · Sionna Therapeutics, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Fleming Harold Edward
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-12+19,959→ 19,959 totalExercise: $16.99Exp: 2035-06-11→ Common Stock (19,959 underlying)
Footnotes (2)
- [F1]The Reporting Person has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.
- [F2]This option vests in full upon the earlier of June 12, 2026 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date.